Bristol-Myers Squibb Company (NYSE: BMY - News) announced today that it has completed its previously announced $2.4 billion acquisition of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE